CD83 and Alzheimer disease: These findings are consistent with an improved power to detect moderate clinicopathological association with CD83(+) microglia in AD subjects within the larger ROSMAP DLPFC snRNA-seq data, rather than necessarily implying a discordance across brain regions or cohorts.